Compugen CEO reports initial share and option holdings
Compugen Ltd’s President and CEO, Ophir Eran, filed an initial statement of ownership showing both ordinary shares and stock options in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Compugen Ltd’s President and CEO, Ophir Eran, filed an initial statement of ownership showing both ordinary shares and stock options in the company. He directly holds 11,375 ordinary shares, including 7,821 restricted stock units that begin vesting in 11 equal quarterly installments starting on March 31, 2026, subject to continued service. He also holds multiple share options over Compugen ordinary shares with exercise prices ranging from $0.8292 to $14.4000, expiring between 2026 and 2035, many of which vest or continue vesting in quarterly installments tied to ongoing service.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Share Option (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (7)
- F1. Includes 7,821 restricted stock units ("RSUs"). The RSUs vest in 11 equal quarterly installments commencing on March 31, 2026, subject to the Reporting Person's continued service to the Issuer.
- F2. Fully vested.
- F3. This option vested 25% on March 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- F4. This option vested 25% on December 31, 2023 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- F5. This option vested 25% on September 30, 2024 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- F6. This option vested 25% on September 30, 2025 and the remainder vested or vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
- F7. This option vests 25% on September 30, 2026 and the remainder vests in equal 12 quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 3 filing by Compugen (CGEN) CEO Ophir Eran show?
What stock options in Compugen (CGEN) are reported for CEO Ophir Eran?
Do the Compugen (CGEN) restricted stock units for CEO Ophir Eran have a vesting schedule?
Are the options held by Compugen (CGEN) CEO fully vested or still vesting?
AI-generated analysis. How Rhea-AI works. Not financial advice.
